Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M307600200 on October 6, 2003

J. Biol. Chem., Vol. 278, Issue 51, 50887-50896, December 19, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/51/50887    most recent
M307600200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, H.
Right arrow Articles by Lu, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, H.
Right arrow Articles by Lu, S. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Induction of Human Methionine Adenosyltransferase 2A Expression by Tumor Necrosis Factor {alpha}

ROLE OF NF-{kappa}B AND AP-1*

Heping Yang, Mamatha R. Sadda{ddagger}, Victor Yu, Ying Zeng, Taunia D. Lee{ddagger}, Xiaopeng Ou, Lixin Chen, and Shelly C. Lu§

From the Division of Gastroenterology and Liver Diseases, USC Liver Disease Research Center, USC-UCLA Research Center for Alcoholic Liver and Pancreatic Diseases, Keck School of Medicine University of Southern California, Los Angeles, California 90033

Two genes (MAT1A and MAT2A) encode for methionine adenosyltransferase (MAT), an essential cellular enzyme responsible for S-adenosylmethionine biosynthesis. MAT1A is expressed mostly in the liver, whereas MAT2A is widely distributed. We showed a switch from MAT1A to MAT2A expression in human hepatocellular carcinoma (HCC), which facilitates cancer cell growth. Using DNase I footprinting analysis, we previously identified a region in the MAT2A promoter protected from DNase I digestion in HCC. This region contains NF-{kappa}B and AP-1 elements, and the present study examined whether they regulate MAT2A promoter activity. We found nuclear binding of NF-{kappa}B and AP-1 to the MAT2A promoter increased in HCC. Tumor necrosis factor {alpha} (TNF{alpha}), which activates both NF-{kappa}B and AP-1, increased MAT2A expression in a dose- and time-dependent manner, binding of both NF-{kappa}B and AP-1 to the MAT2A promoter and MAT2A promoter activity, with the latter effect blocked by site-directed mutagenesis of the NF-{kappa}B and AP-1 binding sites. Blocking NF-{kappa}B with I{kappa}B super-repressor or AP-1 with dominant-negative c-Jun led to decreased basal MAT2A expression and prevented the TNF{alpha}-induced increase in MAT2A expression. Although blocking NF-{kappa}B had no influence on the ability of TNF{alpha} to increase AP-1 nuclear binding, blocking AP-1 with dominant-negative c-Jun prevented the TNF{alpha}-mediated increase in NF-{kappa}B binding. In conclusion, both NF-{kappa}B and AP-1 are required for basal MAT2A expression in HepG2 cells and mediate the increase in MAT2A expression in response to TNF{alpha} treatment. Increased trans-activation of these two sites also contributes to MAT2A up-regulation in HCC.


Received for publication, July 15, 2003 , and in revised form, September 24, 2003.

* This work was supported by National Institutes of Health Grants DK51719, AA12677, and AT1576 (to S. C. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} Recipients of the Postdoctoral Fellowship of the Training Program in Alcoholic Liver and Pancreatic Diseases (Grant T32 AA07578).

§ To whom correspondence should be addressed: Division of Gastrointestinal and Liver Diseases, Hoffman Medical Research Bldg., 415, Dept. of Medicine, USC School of Medicine, 2011 Zonal Ave., Los Angeles, CA 90033. Tel.: 323-442-2441; Fax: 323-442-3234; E-mail: shellylu{at}usc.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
H. Yang, N. Magilnick, C. Lee, D. Kalmaz, X. Ou, J. Y. Chan, and S. C. Lu
Nrf1 and Nrf2 Regulate Rat Glutamate-Cysteine Ligase Catalytic Subunit Transcription Indirectly via NF-{kappa}B and AP-1
Mol. Cell. Biol., July 15, 2005; 25(14): 5933 - 5946.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. M. Simile, G. Pagnan, F. Pastorino, C. Brignole, M. R. De Miglio, M. R. Muroni, G. Asara, M. Frau, M. A. Seddaiu, D. F. Calvisi, et al.
Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF-{kappa}B and Mat1A genes in the early stages of rat liver carcinogenesis
Carcinogenesis, February 1, 2005; 26(2): 417 - 427.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement